Welcome to the latest edition of M&A Insights, an annual review of deal activity and key trends within the pharmaceutical and healthcare sector, by PricewaterhouseCoopers Corporate Finance.
In addition to coverage of the mainstream pharmaceutical sector, we also include separate reviews of the medical devices and biotechnology markets, and fund-raising for the industry as a whole.
This report highlights some of the deals and developments that occurred in 2006 and the first half of 2007, another period of increased M&A activity. Large pharmaceutical players have been a key driver of M&A in their sustained effort to strengthen product pipelines. We have also seen continuing global consolidation in the generics arena.
If you would like to discuss these M&A trends or any other issues facing the pharmaceutical industry, please do not hesitate to contact Neal Ransome, European Pharmaceutical sector leader, or another member of our dedicated sector team.
